DAGMAR ROSA-BJORKESON

Insider Reports History

Location
Bannockburn, IL
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAGMAR ROSA-BJORKESON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xencor Inc Director Common Stock 8,490 $175,573 $20.68 27 Sep 2024 Direct
Xencor Inc Director Stock Option (Right to Buy) 11,971 13 Jun 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct

Insider Reports Filed by DAGMAR ROSA-BJORKESON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XNCR Xencor Inc 27 Sep 2024 1 -$51,762 4 Director 01 Oct 2024, 16:13
XNCR Xencor Inc 13 Jun 2024 2 $0 4 Director 17 Jun 2024, 16:24
/report/000110465923117104-rosa-bjorkeson-dagmar-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 5 -$501,429 4 Director 13 Nov 2023, 14:43
XNCR Xencor Inc 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 17:52
/report/000110465923064841-rosa-bjorkeson-dagmar-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:39
XNCR Xencor Inc 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:49
/report/000110465922065901-rosa-bjorkeson-dagmar-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:16
XNCR Xencor Inc 24 Jun 2021 1 $0 4 Director 25 Jun 2021, 20:00
/report/000110465921075217-rosa-bjorkeson-dagmar-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:01